GLOMERULAR DISEASES
Henok J ( MD)
Glomerular Diseases
 Glomerular anatomy and physiology
 Pathology and classification of Glomerular diseases
 Clinical presentation
 Investigation of Glomerular diseases
 Nephrotic syndrome
 Nephritic syndrome(AGN/RPGN)
 Asymptomatic proteinuria and hematuria
Kidney compartments
 Glomerulus
◦ Filtration of plasma
 Tubulointerstitium
◦ Modification of glomerular filtrate
◦ Production Epo and Vit D3
 Vascular
◦ Maintain blood flow and monitor pressure
Anatomy
 The blood flow to the kidneys averages 20 % the cardiac
output.
Per weight ..... 4X higher than the liver & skeletal muscle
...... 8x higher than the coronary blood flow
 Blood enters the kidney through the renal arteries and passes
serial branches to enter the glomeruli via the afferent
arterioles.
 The portion of the plasma not filtered across the glomeruli
leaves via the efferent arterioles.
 The glomerulus is a tuft of capillaries (specialized
microvasculature) that is interposed b/n the afferent & efferent
arterioles
Anatomy
 Each glomerulus is enclosed within an epithelial cell capsule =
Bowman's capsule(BC)
 The BC is continuous with the epithelial cells that surround the
glomerular capillaries & with the cells of the proximal tubule.
 The glomerular capillary wall consists of three layers:
1. Fenestrated endothelial cell
2. Glomerular basement membrane (GBM)
3. Epithelial cell
• The epithelial cells are attached to the GBM by discrete foot
processes.
• The pores b/n the foot processes (slit pores) are closed by a thin
membrane called the slit diaphragm.
Glomerular Architecture
Glomerular Anatomy
 Glomerular apparatus
◦ Endothelium
◦ Basement membrane
◦ Podocytes
Function
 Filtration of small solutes (such as Na and urea) and water,
while restricting the passage of larger molecules (larger
proteins).
 The free filtration of small solutes like Na, K and urea, allows
the kidney to maintain the steady state by excreting the load.
 Restricted filtration of larger proteins prevents problems like
negative nitrogen balance, hypoalbuminemia, & infection due to
the loss IgG.
 Filtration is effected by size and charge selectivity of GBM.
Smaller and Cationic molecules are filtered better.
 The glomerular cells also have synthetic(Production of GBM),
phagocytic(Mesangial cell), and endocrine(NO, endothelin)
functions.
Glomerular diseases
 Heterogeneous group of inflammatory and /or non
inflammatory insults to the filtering unit of the kidney.
 The hallmark of glomerular diseases is an alteration in
glomerular permeablity and selectivity resulting in proteinuria
and /or hematuria.
 Classification
- Clinical: primary x secondary
- According to time period: acute x subacute x chronic
- According to renal biopsy: focal x segmental x diffuse
- According number of cells: non-proliferative x proliferative
Pathology of Glomerular diseases (Glomerulonephritis)
 The majority of GN cases involve immune mechanisms, most
often humoral immune responses.
 In some cases immune complexes are formed in situ within the
glomeruli. In other forms of preformed circulating immune
complexes are trapped.
 Non-immune injury-
- Numerous Pathologies renal or extrarenal in origin, can lead to
glomerulosclerosis .
-The remaining glomeruli are subjected to increased
intraglomerular pressure, which produces glomerular injury .
This process is called hyperfiltration injury.
 There are also some inherited glomerular diseases.
Pathology
 The glomerulus will react in a limited number of ways with a
variable degree of severity.
 One pattern can have multiple etiological causes and one
etiology can have different pathologic pattern, so all biopsies
must be evaluated with clinical correlation.
- pathological changes most often encountered are as follows:
1.Increase in the number of cells (Proliferation), affecting either:
▪ mesangial cells, with or without endothelial cells
▪ epithelial cells, leading to the formation of cellular
crescents
obliterating the Bowman's space.
2. Necrosis of one or more segments of the glomerulus
3. GBM thickening
4 . Sclerosis of one segment or of entire glomerulus
5. Trapping of immunoglobulins or complement proteins
Pathology
 The following vocabulary is used to characterize the distribution of
the lesions:
* diffuse: most glomeruli are affected
* focal: only a proportion ( less than half) of the glomeruli
are affected
* global: the entire glomerulus is affected
* segmental: part of an individual glomerulus is affected
Clinical presentation
 Patients with glomerular diseases usually present with
one of following
 Nephrotic syndrome
 Nephritic syndrome
 Asymptomatic proteinuria
 Asymptomatic Hematuria
 Proteinuric CKD
• The commonest presentations are the nephrotic and nephritic
syndromes.
 Note that these represent two broad categories of clinical
presentation and are not specific glomerulopathies by
themselves.
• Nephritic and nephrotic syndromes are not mutually
exclusive (There is a nephrotic-nephritic
presentation)
Nephrotic syndrome
Nephrotic syndrome
 Definition
-A clinical syndrome characterized by renal and extra renal
features the most important of which are
 proteinuria of >3.5 grams per1.73m2 per 24 h (in practice >3.0 -
3.5 grams /24 h) or spot urine protein:creatinine ratio of >300-350
mg/mmol- this is the central problem
 Hypoalbuminemia,
 Edema,
 Hyperlipidemia
 Lipiduria and
 Hypercoagulability
Nephrotic syndrome-proteinuria
 Proteinuria — There are three basic types of proteinuria;
glomerular; tubular; and overflow.
 It is glomerular proteinuria that is responsible for protein loss in
the nephrotic syndrome.
 Albumin is the principal urinary protein lost
 Other plasma proteins including clotting inhibitors, transferrin,
and hormone carrying proteins such as vitamin D-binding
protein may be lost as well.
Nephrotic syndrome- Hypoalbuminemia
 Serum albumin falls as a consequence of the proteinuria
 Hepatic albumin synthesis increases in response to the
albumin loss.
 The normal liver has a synthetic capacity to increase the total
albumin pool by approximately 25 grams per day.
 It remains unclear why the liver of most patients with
nephrotic syndrome is unable to increase albumin synthesis
sufficiently to normalize the plasma albumin concentration.
 Renal catabolism of filtered protein is leading to
underestimation of the protein loss from the body is a
speculated mechanism.
Nephrotic syndrome -edema
 Two mechanisms have been proposed
Decrease in plasma oncotic pressure.
Primary renal sodium retention in the collecting tubules
Nephrotic syndrome- Hyperlipidemia and
lipiduria
 The two most common lipid abnormalities in the nephrotic
syndrome are hypercholesterolemia and hypertriglyceridemia.
 Decreased plasma oncotic pressure appears to stimulate hepatic
lipoprotein synthesis resulting in hypercholesterolemia.
 Impaired metabolism is primarily responsible for nephrotic
hypertriglyceridemia.
 Lipiduria is usually present in the nephrotic syndrome.
 Urinary lipid may be present in the sediment, entrapped in casts,
enclosed by the plasma membrane of degenerative epithelial
cells(oval fat bodies) .
 Under polarized light oval fat bodies have the appearance of a
Maltese cross
Nephrotic syndrome-lipiduria
Nephrotic syndrome -complications
 Protein malnutrition — A loss in lean body mass often occurs
in patients with marked proteinuria, although it may be masked
by concurrently increasing edema.
 Decreased circulatory volume —
- severe hypoalbuminemia causes fluid movement from the
intravasular space into the interstitium
- over diuresis
 Acute Kidney injury — several factors including
hypovolemia, interstitial edema, ischemic tubular injury play a
role
Nephrotic syndrome -complications
 Thromboembolism — Patients with the nephrotic syndrome
have an increased incidence of arterial and venous
thromboemboli, particularly deep vein and renal vein thrombosis
.
- A variety of hemostatic abnormalities have been described,
 decreased levels of antithrombin and plasminogen (due to urinary
losses),
 increased platelet activation,
 hyperfibrinogenemia,
 inhibition of plasminogen activation
-Renal vein thrombosis is found disproportionately in patients with
membranous nephropathy,
 Infection— Patients with the nephrotic syndrome are
susceptible to infections.
- Low levels of immunoglobulin G may play a role.
Nephrotic syndrome -complications
 Vitamin D deficiency.
 A decrease in thyroxine-binding globulins can cause marked
changes in various thyroid function tests, although patients
are clinically euthyroid.
 Anemia - perhaps due to the urinary loss or impaired
synthesis of erythropoietin and loss of transfferin.
Nephrotic Syndrome- Common causes
 Renal
◦ Minimal Change
◦ Membranous
◦ FSGS
 “Systemic”
◦ DM
◦ MM/Amyloidosis
◦ SLE
MCD- Minimal change disease/Nil disease/lipoid
nephrosis
 Most common cause of the
nephrotic syndrome in children
 ~10-15% of nephrotic syndrome in
adults, third most common after
MN and FSGS
◦ More common in Hispanics,
Asians, Arabs and Caucasians
 clinical and pathological entity
defined by selective proteinuria
and hypoalbuminemia that occurs
in the absence of
◦ cellular glomerular infiltrates or
◦ immunoglobulin deposits
MCD
 Usually idiopathic
 Can be secondary to
systemic disease or
drugs
 Treatment of
idiopathic MCD
- steroids- MCD is very
responsive to
steroids
- Other
Immunosuppressive -
for steroid resistant
or relapse.
FSGS – Focal segmental glomerulosclerosis
 Typically idiopathic,
Associated diseases
HIV , Obesity , Sickle cell anemia,
malignancies,
Chronic vesicoureteral reflux.
 This disease entity has a name based on the
nature of its histologic changes: focal and
segmental
 No inflammatory cells are present in the
glomeruli
 sclerosis of the glomeruli are more pronounced
at the cortico-medullary junction.
 Most common cause of idiopathic nephrotic
syndrome in African Americans
 Clinically, patients present with the nephrotic
syndrome, hematuria, hypertension and
decreased renal function.
FSGS
• 50% of patients develop end-stage renal failure 10 years after the
onset of the disease.
• Proteinuria and FSGS is a final common pathway
after many different forms of renal injury– secondary FSGS
To differentiate primary from secondary FSGS:
– foot processes in all glomeruli are abnormal in
primary FSGS
– Foot processes only abnormal in visibly
affected glomeruli in secondary FSGS
– Serum albumin often near normal
Treatment
• 15% respond to steroids
• Other immunosuppression
Cyclosporine, cyclophosphamide
Membranous nephropathy
 Heavy proteinuria with nephrotic syndrome is the usual
presentation of membranous nephropathy.
Cont.
 A common cause of the nephrotic syndrome in adults.
 Pathological changes are characterized by thickening of the capillary wall. No
glomerular hypercellularity or inflammatory changes .
 Few red blood cells are found in urine, no hypertension at the early stage. Renal
function is normal initially and progresses very slowly.
 10% of adults are in end-stage renal failure 10 yrs after the onset.
.
 Membranous nephropathy is occasionally caused by an infection (e.g. Hepatitis B),
autoimmune disease (e.g. SLE), or an underlying malignancy.
TREATMENT
 Immunosupressive,
- idiopathic with poor prognostic indicator ; Male
Renal dysfunction.
Hypertesion
Membranous nephropathy
TREATMENT
 Specific therapy : underlying causes
-
Immunosuppressive,idiopathic
- Treating infectious causes
Syphilis
Hep B
Hep C,HIV etc
- avoid offending agent
 Non Immunologic – universal rx for all
Nephrotic syndrome
Non immunologic Therapy for all
Nephrotic syndrome
 Treat underlying cause
 Salt restrict
◦ <2g sodium per day
 Diuretics
◦  doses loop as reduced delivery to tubule
◦ Combine with thiazide
 Renin-angiotensin blockade
 Treatment of hypertension esp. ACEI, ARB ,Target < 140/90
 Treatment of hypercholesterolemia
Target LDL < 2.0
 Calcium and vit D to reduce bone loss if steroid
therapy is prolonged
 Bactrim for PCP prophyllaxis if steroids
 INH for TB prophylaxis if immunosuppressed
 ?Anticoagulant if high risk?
Acute nephritic syndrome –
AGN/RPGN
Acute Nephritic Syndrome
Syndrome
characterised in
typical cases by:
 haematuria
 oliguria
 oedema
 hypertension
 reduced GFR
 proteinuria
AGN VS RPGN
 AGN is the clinical correlate
of diffuse proliferative
glomerulonephritis.
• AGN presents with sudden
onset ( days)of haematuria
,oliguria ,oedema and
hypertension
• Causes - Post infectious(
commonest PSGN),
SLE,MPGN,cryoglobul.GN
• AGN and RPGN are part of a
spectrum of presentations of
immunologically mediated
proliferative
glomerulonephritis
AGN Vs RPGN
 RPGN is characterized by
rapidly progressive
deterioration in renal
function associated with
oliguria.
 Decline in GFR occurs over
weeks.
 RPGN is the clinical
correlate of crescentic
glomerulonephritis
 Many crescents are seen on
biopsy.
Linear Deposits
Granular
Deposits
Clinical Features of the Acute Nephritic
Syndrome (AGN/RPGN)
 haematuria is usually macroscopic with pink or brown urine
(like coca cola)
 oliguria may be overlooked or absent in milder cases
 oedema is usually mild and is often just peri-orbital- weight
gain may be detected
 hypertension common and associated with raised urea and
creatinine
 proteinuria is variable but usually less than in the nephrotic
syndrome
Investigation
 Basline measurements :
↑ Urea
↑ Creatinine
Urinalysis :
a) Urine microscopy (red cell cast)
b) proteinuria
Diagnostically useful tests :
 Culture (swab from throat or infected skin)
 Serum ASO titre, Anti DNAase
 Hepatitis B surface antigen
 Hepatitis C antibody
 HIV screen -- HIVIC
 Anti DNA , ANA– SLE
 ANCAs --- Small vessel vasculitidis
 ↓C3,4 – lupus, post infectious,MPGN
 Cryoglobulins & RF -- Cryoglobulinemia
 Anti—GBM Abs -- GBM disease
 Renal biopsy
Complications of the Nephritic
Syndrome
 Hypertensive encephalopathy (seizures, coma)
 Fluid oveload -pulmonary oedema
 Uraemia requiring dialysis
 Chronic glomerulonephritis and CKI
 HTN
Management & Prognosis
Post streptococcal GN
- Has a GOOD prognosis .
- Supportive measures until spontaneous recovery.
- Control HTN.
- Fluid balance.
-Oliguric with fluid overload--- dialysis
GN complicating SLE or systemic vasculitides :
immunosuppression with prednisolone,
cyclophosphamide or azathioprine/ MMF.

2 GLOMERULAR DISEASES.pptx

  • 1.
  • 2.
    Glomerular Diseases  Glomerularanatomy and physiology  Pathology and classification of Glomerular diseases  Clinical presentation  Investigation of Glomerular diseases  Nephrotic syndrome  Nephritic syndrome(AGN/RPGN)  Asymptomatic proteinuria and hematuria
  • 3.
    Kidney compartments  Glomerulus ◦Filtration of plasma  Tubulointerstitium ◦ Modification of glomerular filtrate ◦ Production Epo and Vit D3  Vascular ◦ Maintain blood flow and monitor pressure
  • 5.
    Anatomy  The bloodflow to the kidneys averages 20 % the cardiac output. Per weight ..... 4X higher than the liver & skeletal muscle ...... 8x higher than the coronary blood flow  Blood enters the kidney through the renal arteries and passes serial branches to enter the glomeruli via the afferent arterioles.  The portion of the plasma not filtered across the glomeruli leaves via the efferent arterioles.  The glomerulus is a tuft of capillaries (specialized microvasculature) that is interposed b/n the afferent & efferent arterioles
  • 6.
    Anatomy  Each glomerulusis enclosed within an epithelial cell capsule = Bowman's capsule(BC)  The BC is continuous with the epithelial cells that surround the glomerular capillaries & with the cells of the proximal tubule.  The glomerular capillary wall consists of three layers: 1. Fenestrated endothelial cell 2. Glomerular basement membrane (GBM) 3. Epithelial cell • The epithelial cells are attached to the GBM by discrete foot processes. • The pores b/n the foot processes (slit pores) are closed by a thin membrane called the slit diaphragm.
  • 7.
  • 8.
    Glomerular Anatomy  Glomerularapparatus ◦ Endothelium ◦ Basement membrane ◦ Podocytes
  • 9.
    Function  Filtration ofsmall solutes (such as Na and urea) and water, while restricting the passage of larger molecules (larger proteins).  The free filtration of small solutes like Na, K and urea, allows the kidney to maintain the steady state by excreting the load.  Restricted filtration of larger proteins prevents problems like negative nitrogen balance, hypoalbuminemia, & infection due to the loss IgG.  Filtration is effected by size and charge selectivity of GBM. Smaller and Cationic molecules are filtered better.  The glomerular cells also have synthetic(Production of GBM), phagocytic(Mesangial cell), and endocrine(NO, endothelin) functions.
  • 10.
    Glomerular diseases  Heterogeneousgroup of inflammatory and /or non inflammatory insults to the filtering unit of the kidney.  The hallmark of glomerular diseases is an alteration in glomerular permeablity and selectivity resulting in proteinuria and /or hematuria.  Classification - Clinical: primary x secondary - According to time period: acute x subacute x chronic - According to renal biopsy: focal x segmental x diffuse - According number of cells: non-proliferative x proliferative
  • 11.
    Pathology of Glomerulardiseases (Glomerulonephritis)  The majority of GN cases involve immune mechanisms, most often humoral immune responses.  In some cases immune complexes are formed in situ within the glomeruli. In other forms of preformed circulating immune complexes are trapped.  Non-immune injury- - Numerous Pathologies renal or extrarenal in origin, can lead to glomerulosclerosis . -The remaining glomeruli are subjected to increased intraglomerular pressure, which produces glomerular injury . This process is called hyperfiltration injury.  There are also some inherited glomerular diseases.
  • 12.
    Pathology  The glomeruluswill react in a limited number of ways with a variable degree of severity.  One pattern can have multiple etiological causes and one etiology can have different pathologic pattern, so all biopsies must be evaluated with clinical correlation. - pathological changes most often encountered are as follows: 1.Increase in the number of cells (Proliferation), affecting either: ▪ mesangial cells, with or without endothelial cells ▪ epithelial cells, leading to the formation of cellular crescents obliterating the Bowman's space. 2. Necrosis of one or more segments of the glomerulus 3. GBM thickening 4 . Sclerosis of one segment or of entire glomerulus 5. Trapping of immunoglobulins or complement proteins
  • 13.
    Pathology  The followingvocabulary is used to characterize the distribution of the lesions: * diffuse: most glomeruli are affected * focal: only a proportion ( less than half) of the glomeruli are affected * global: the entire glomerulus is affected * segmental: part of an individual glomerulus is affected
  • 14.
    Clinical presentation  Patientswith glomerular diseases usually present with one of following  Nephrotic syndrome  Nephritic syndrome  Asymptomatic proteinuria  Asymptomatic Hematuria  Proteinuric CKD • The commonest presentations are the nephrotic and nephritic syndromes.  Note that these represent two broad categories of clinical presentation and are not specific glomerulopathies by themselves. • Nephritic and nephrotic syndromes are not mutually exclusive (There is a nephrotic-nephritic presentation)
  • 16.
  • 17.
    Nephrotic syndrome  Definition -Aclinical syndrome characterized by renal and extra renal features the most important of which are  proteinuria of >3.5 grams per1.73m2 per 24 h (in practice >3.0 - 3.5 grams /24 h) or spot urine protein:creatinine ratio of >300-350 mg/mmol- this is the central problem  Hypoalbuminemia,  Edema,  Hyperlipidemia  Lipiduria and  Hypercoagulability
  • 18.
    Nephrotic syndrome-proteinuria  Proteinuria— There are three basic types of proteinuria; glomerular; tubular; and overflow.  It is glomerular proteinuria that is responsible for protein loss in the nephrotic syndrome.  Albumin is the principal urinary protein lost  Other plasma proteins including clotting inhibitors, transferrin, and hormone carrying proteins such as vitamin D-binding protein may be lost as well.
  • 19.
    Nephrotic syndrome- Hypoalbuminemia Serum albumin falls as a consequence of the proteinuria  Hepatic albumin synthesis increases in response to the albumin loss.  The normal liver has a synthetic capacity to increase the total albumin pool by approximately 25 grams per day.  It remains unclear why the liver of most patients with nephrotic syndrome is unable to increase albumin synthesis sufficiently to normalize the plasma albumin concentration.  Renal catabolism of filtered protein is leading to underestimation of the protein loss from the body is a speculated mechanism.
  • 20.
    Nephrotic syndrome -edema Two mechanisms have been proposed Decrease in plasma oncotic pressure. Primary renal sodium retention in the collecting tubules
  • 21.
    Nephrotic syndrome- Hyperlipidemiaand lipiduria  The two most common lipid abnormalities in the nephrotic syndrome are hypercholesterolemia and hypertriglyceridemia.  Decreased plasma oncotic pressure appears to stimulate hepatic lipoprotein synthesis resulting in hypercholesterolemia.  Impaired metabolism is primarily responsible for nephrotic hypertriglyceridemia.  Lipiduria is usually present in the nephrotic syndrome.  Urinary lipid may be present in the sediment, entrapped in casts, enclosed by the plasma membrane of degenerative epithelial cells(oval fat bodies) .  Under polarized light oval fat bodies have the appearance of a Maltese cross
  • 22.
  • 23.
    Nephrotic syndrome -complications Protein malnutrition — A loss in lean body mass often occurs in patients with marked proteinuria, although it may be masked by concurrently increasing edema.  Decreased circulatory volume — - severe hypoalbuminemia causes fluid movement from the intravasular space into the interstitium - over diuresis  Acute Kidney injury — several factors including hypovolemia, interstitial edema, ischemic tubular injury play a role
  • 24.
    Nephrotic syndrome -complications Thromboembolism — Patients with the nephrotic syndrome have an increased incidence of arterial and venous thromboemboli, particularly deep vein and renal vein thrombosis . - A variety of hemostatic abnormalities have been described,  decreased levels of antithrombin and plasminogen (due to urinary losses),  increased platelet activation,  hyperfibrinogenemia,  inhibition of plasminogen activation -Renal vein thrombosis is found disproportionately in patients with membranous nephropathy,  Infection— Patients with the nephrotic syndrome are susceptible to infections. - Low levels of immunoglobulin G may play a role.
  • 25.
    Nephrotic syndrome -complications Vitamin D deficiency.  A decrease in thyroxine-binding globulins can cause marked changes in various thyroid function tests, although patients are clinically euthyroid.  Anemia - perhaps due to the urinary loss or impaired synthesis of erythropoietin and loss of transfferin.
  • 26.
    Nephrotic Syndrome- Commoncauses  Renal ◦ Minimal Change ◦ Membranous ◦ FSGS  “Systemic” ◦ DM ◦ MM/Amyloidosis ◦ SLE
  • 27.
    MCD- Minimal changedisease/Nil disease/lipoid nephrosis  Most common cause of the nephrotic syndrome in children  ~10-15% of nephrotic syndrome in adults, third most common after MN and FSGS ◦ More common in Hispanics, Asians, Arabs and Caucasians  clinical and pathological entity defined by selective proteinuria and hypoalbuminemia that occurs in the absence of ◦ cellular glomerular infiltrates or ◦ immunoglobulin deposits
  • 28.
    MCD  Usually idiopathic Can be secondary to systemic disease or drugs  Treatment of idiopathic MCD - steroids- MCD is very responsive to steroids - Other Immunosuppressive - for steroid resistant or relapse.
  • 29.
    FSGS – Focalsegmental glomerulosclerosis  Typically idiopathic, Associated diseases HIV , Obesity , Sickle cell anemia, malignancies, Chronic vesicoureteral reflux.  This disease entity has a name based on the nature of its histologic changes: focal and segmental  No inflammatory cells are present in the glomeruli  sclerosis of the glomeruli are more pronounced at the cortico-medullary junction.  Most common cause of idiopathic nephrotic syndrome in African Americans  Clinically, patients present with the nephrotic syndrome, hematuria, hypertension and decreased renal function.
  • 30.
    FSGS • 50% ofpatients develop end-stage renal failure 10 years after the onset of the disease. • Proteinuria and FSGS is a final common pathway after many different forms of renal injury– secondary FSGS To differentiate primary from secondary FSGS: – foot processes in all glomeruli are abnormal in primary FSGS – Foot processes only abnormal in visibly affected glomeruli in secondary FSGS – Serum albumin often near normal Treatment • 15% respond to steroids • Other immunosuppression Cyclosporine, cyclophosphamide
  • 31.
    Membranous nephropathy  Heavyproteinuria with nephrotic syndrome is the usual presentation of membranous nephropathy.
  • 32.
    Cont.  A commoncause of the nephrotic syndrome in adults.  Pathological changes are characterized by thickening of the capillary wall. No glomerular hypercellularity or inflammatory changes .  Few red blood cells are found in urine, no hypertension at the early stage. Renal function is normal initially and progresses very slowly.  10% of adults are in end-stage renal failure 10 yrs after the onset. .  Membranous nephropathy is occasionally caused by an infection (e.g. Hepatitis B), autoimmune disease (e.g. SLE), or an underlying malignancy. TREATMENT  Immunosupressive, - idiopathic with poor prognostic indicator ; Male Renal dysfunction. Hypertesion
  • 33.
  • 34.
    TREATMENT  Specific therapy: underlying causes - Immunosuppressive,idiopathic - Treating infectious causes Syphilis Hep B Hep C,HIV etc - avoid offending agent  Non Immunologic – universal rx for all Nephrotic syndrome
  • 35.
    Non immunologic Therapyfor all Nephrotic syndrome  Treat underlying cause  Salt restrict ◦ <2g sodium per day  Diuretics ◦  doses loop as reduced delivery to tubule ◦ Combine with thiazide  Renin-angiotensin blockade  Treatment of hypertension esp. ACEI, ARB ,Target < 140/90  Treatment of hypercholesterolemia Target LDL < 2.0  Calcium and vit D to reduce bone loss if steroid therapy is prolonged  Bactrim for PCP prophyllaxis if steroids  INH for TB prophylaxis if immunosuppressed  ?Anticoagulant if high risk?
  • 37.
  • 39.
    Acute Nephritic Syndrome Syndrome characterisedin typical cases by:  haematuria  oliguria  oedema  hypertension  reduced GFR  proteinuria
  • 40.
    AGN VS RPGN AGN is the clinical correlate of diffuse proliferative glomerulonephritis. • AGN presents with sudden onset ( days)of haematuria ,oliguria ,oedema and hypertension • Causes - Post infectious( commonest PSGN), SLE,MPGN,cryoglobul.GN • AGN and RPGN are part of a spectrum of presentations of immunologically mediated proliferative glomerulonephritis
  • 41.
    AGN Vs RPGN RPGN is characterized by rapidly progressive deterioration in renal function associated with oliguria.  Decline in GFR occurs over weeks.  RPGN is the clinical correlate of crescentic glomerulonephritis  Many crescents are seen on biopsy.
  • 43.
  • 44.
    Clinical Features ofthe Acute Nephritic Syndrome (AGN/RPGN)  haematuria is usually macroscopic with pink or brown urine (like coca cola)  oliguria may be overlooked or absent in milder cases  oedema is usually mild and is often just peri-orbital- weight gain may be detected  hypertension common and associated with raised urea and creatinine  proteinuria is variable but usually less than in the nephrotic syndrome
  • 45.
    Investigation  Basline measurements: ↑ Urea ↑ Creatinine Urinalysis : a) Urine microscopy (red cell cast) b) proteinuria
  • 46.
    Diagnostically useful tests:  Culture (swab from throat or infected skin)  Serum ASO titre, Anti DNAase  Hepatitis B surface antigen  Hepatitis C antibody  HIV screen -- HIVIC  Anti DNA , ANA– SLE  ANCAs --- Small vessel vasculitidis  ↓C3,4 – lupus, post infectious,MPGN  Cryoglobulins & RF -- Cryoglobulinemia  Anti—GBM Abs -- GBM disease  Renal biopsy
  • 47.
    Complications of theNephritic Syndrome  Hypertensive encephalopathy (seizures, coma)  Fluid oveload -pulmonary oedema  Uraemia requiring dialysis  Chronic glomerulonephritis and CKI  HTN
  • 48.
    Management & Prognosis Poststreptococcal GN - Has a GOOD prognosis . - Supportive measures until spontaneous recovery. - Control HTN. - Fluid balance. -Oliguric with fluid overload--- dialysis GN complicating SLE or systemic vasculitides : immunosuppression with prednisolone, cyclophosphamide or azathioprine/ MMF.